- M101-1 (Midstream urine sample: Streptococcus constellatus)
- M094-1 (Catheter urine sample: Proteus penneri and Enterococcus faecalis)
- M092-1 (MSU, Morganella morganii)
- M084-1 (MSU, Enterococcus faecalis) Reporting an AST comment is no longer an acceptable process.
- M082-1 (MSU, CNS)
- M074-1 (MSU, VRE E. faecium)
- M073-1 (MSU, mixed flora-please repeat)
- M071-2
(MSU,
community acquired MRSA) See pdf
file for Table 5. The most common microbial etiologies for urinary
tract infections in adults.
- M064-3
(MSU, E. coli, AmpC positive, ESBL negative)
- M063-1
(MSU, Proteus mirabilis)
- M062-3
(in and out catheter: Klebsiella pneumoniae, ESBL strain)
- M061-1
(MSU: E. coli, same strain as in M24-1 )
- M054-3
(urine: Salmonella Enteritidis)
- M053-1
(MSU (patient allergic to penicillin: group B streptococci / Streptococcus
agalactiae)
- M051-1
(Catheter urine:
Escherichia coli and Morganella morganii ); M72-1 (rehabilitation patient - Morganella morganii)
- M044-1
(mixed culture, suggestive of contamination); M84-1 (mix of 4 organisms); U73 (mixed flora with VRE)
- M042-1 (Staphylococcus saprophyticus); M81-1 (Staphylococcus saprophyticus);
M93-1 (coagulase-negative staphylococcus [S. epidermidis]) ;
M83-1 (Staphylococcus lugdunensis)
- M034-1 (Pseudomonas aeruginosa); M92-1 (low count - E. coli, Pseudomonas aeruginosa); M73-1 (Pseudomonas aeruginosa)
- M033-1 (Klebsiella pneumoniae, ESBL strain)
- M032-1 (Candida tropicalis); M73-5 (Candida krusei)
- M024-3 (E. coli with ESBL mediated resistance); M23-1 (E. coli - ESBL strain)
- M023-1 (E. coli and Klebsiella pneumoniae)
- M022-4 (Enterobacter cloacae - ampC resistance)
- M021-1 (Proteus mirabilis - include a fluoroquinolone result); M91-1 (Proteus mirabilis)
- M014-1 (catheter - Providencia stuartii)
- M012-1 (group B streptococci)
- M011-1 & M22-1 (E.
coli, resistant to cephalothin, susceptible to cefazolin)
- M24-1 (E. coli, resistant to ampicillin, gentamicin, SXT, & fluoroquinolones;
susceptible to cephalothin, cefazolin & nitrofurantoin)
- M21-1 (E. coli - susceptible to ampicillin, cephalothin, cefazolin,,
& SXT; resistant to gentamicin)
- M94-1 (Citrobacter koseri)
- M63-3 (archived critique-1996: Edwardsiella tarda)
- M61-4 (archived critique-1996: Corynebacterium urealyticum)
- CMPT
Connections 3,
4 2000 - Clinical Relevancy and Continuous Quality Improvement (
pdf-format)
Some
older archived critiques are included in this list, but CMPT
advises visitors to also consult recent literature.
|